Ronald L. Drengler, MD

Articles by Ronald L. Drengler, MD

Alternative Dosing Schedules for Irinotecan

ByMace L. Rothenberg, MD,John G. Kuhn, PharmD,Larry J. Schaaf, PhD,Ronald L. Drengler, MD,S. Gail Eckhardt, MD,Miguel A. Villalona-calero, MD,Eric K. Rowinsky, MD,Daniel D. Von Hoff, MD,Langdon L. Miller, MD,Rrobert G. Petit, PhD,Lisa Hammond, MD

Most of the clinical experience with irinotecan (CPT-11 [Camptosar]) has been with either a weekly or an every-3-week schedule. Recent phase I trials have explored new routes and schedules of administration. One approach

Latest Updated Articles